Long-term safety of regorafenib (REG) in advanced gastrointestinal stromal tumors (GIST): updated safety data of the phase 3 GRID trialGeorge D. Demetri,Peter Reichardt,Y-K. Kang,J-Y. Blay,Heikki Joensuu,C. Kappeler, C. Wuchter-Czerwony,J. Chung,A. Wagner,Paolo G. CasaliANNALS OF ONCOLOGY(2016)引用 1|浏览38暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要